Jakob Dupont, Director at Pyxis Oncology, Inc. (PYXS), sold 35,000 shares at $3.06 ($107K) on 2026-06-30, disclosed to the SEC on 2026-07-02.
Scheduled sale ($107k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |
| ATRA | SELL | 2022-03-03 | $22K | — | Filing → |